Linda Grais
CIK 1413306 · President and CEO · last filed 2025-06-16
Linda Grais is a President and CEO who has filed 53 SEC Form 4 insider transactions across 4 companies since 2009. The most recent filing, for CRVS, was dated Jun 16, 2025. Across all open-market trades the lifetime net is −$1.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $119.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$119.3K
4
53
-$1.53M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRVS | Director | 10,000 | $11.93 | $119.3K | $24.5K | 13 | 2025-06-16 |
| Oruka Therapeutics, Inc. (ABIO) Delisted | Director | 491,889 | $28.80 | $14.17M | -$1.55M | 14 | 2024-01-31 |
| PRA Health Sciences, Inc. (PRAH) Delisted | Director | 0 | $165.21 | $0 | $0 | 8 | 2021-07-01 |
| Zosano Pharma Corp (ZSAN) Delisted | Director | 22,500 | $0.56 | $12.5K | $0 | 5 | 2021-06-14 |
Recent Filings
53 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-16 | CRVS | Grant (A) | — | $0 | EDGAR |
| 2024-06-17 | CRVS | Grant (A) | — | $0 | EDGAR |
| 2024-01-31 | Oruka Therapeutics, Inc. (ABIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-12-08 | CRVS | Grant (A) | — | $0 | EDGAR |
| 2023-06-20 | CRVS | Grant (A) | — | $0 | EDGAR |
| 2023-05-16 | CRVS | Buy (P) | +10,000 | $24.5K | EDGAR |
| 2022-12-19 | Oruka Therapeutics, Inc. (ABIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-08-15 | CRVS | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | CRVS | Grant (A) | — | $0 | EDGAR |
| 2021-09-13 | CRVS | Grant (A) | — | $0 | EDGAR |